We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Subclinical Hypothyroidism Overdiagnosis in Pregnant Women—Reply

Spyridoula Maraka, MD1; Naykky Singh Ospina, MD1; Victor M. Montori, MD1
[+] Author Affiliations
1Knowledge and Evaluation Research Unit, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota
JAMA Intern Med. 2015;175(11):1873. doi:10.1001/jamainternmed.2015.5553.
Text Size: A A A
Published online


In Reply We were pleased to read the letter from the Rotterdam Thyroid Center, and we thank Dr Korevaar and colleagues for their comments in response to our recent publication.1

Currently, in the absence of a laboratory trimester-specific reference range for thyroid-stimulating hormone (TSH) levels, the guidelines recommend a fixed upper limit of 2.5 mIU/L for first trimester and 3.0 mIU/L for second and third trimesters of pregnancy.2 Implementation of a fixed cutoff rather than a population-based cutoff for TSH levels could lead to overdiagnosis of subclinical hypothyroidism in pregnancy and to subsequent overtreatment. As Korevaar et al point out, the reference range for TSH and free thyroxine vary with geography and ethnic origin.3,4 With multiple population-based studies showing an upper trimester–specific TSH limit higher than 2.5 or 3 mIU/L,4 the current fixed cutoff TSH levels seem problematic.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





November 1, 2015
Tim. I. M. Korevaar, MD; Marco Medici, MD, PhD; Robin P. Peeters, MD, PhD
1Rotterdam Thyroid Center, Erasmus University Medical Center, the Netherlands
JAMA Intern Med. 2015;175(11):1872-1873. doi:10.1001/jamainternmed.2015.5550.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...